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Structural analysis of MRP1-NBD1 revealed that the Walker A S685 forms hydrogen-bond with the Walker B D792 and interacts with
magnesium and the β-phosphate of the bound ATP. We have found that substitution of the D792 with leucine resulted in misfolding of the protein.
In this report we tested whether substitution of the S685 with residues that prevent formation of this hydrogen-bond would also cause misfolding.
Indeed, substitution of the S685 with residues potentially preventing formation of this hydrogen-bond resulted in misfolding of the protein. In
addition, some substitutions that might form hydrogen-bond with D792 also yielded immature protein. All these mutants are temperature-sensitive
variants. However, these complex-glycosylated mature mutants prepared from the cells grown at 27 °C still significantly affect ATP binding and
ATP-dependent solute transport. In contrast, substitution of the S685 with threonine yielded complex-glycosylated mature protein that is more
active than the wild-type MRP1, indicating that the interaction between the hydroxyl group of 685 residue and the carboxyl group of D792 plays a
crucial role for the protein folding and the interactions of the hydroxyl group at 685 with magnesium and the β-phosphate of the bound ATP play
an important role for ATP-binding and ATP-dependent solute transport.
© 2007 Elsevier B.V. All rights reserved.Keywords: MRP1; Protein folding; Hydrogen-bond formation; Complex-glycosylated mature protein; ATP binding/hydrolysis; ATP-dependent solute transport1. Introduction
Over-expression of multidrug resistance protein (MRP1)
coffers the cancer cells resistant to multiple anticancer drugs
(MDR) [1,2]. Hydrophobicity plot analysis of MRP1 protein
[3,4] reveals that this protein has two nucleotide binding
domains (NBD) and two transmembrane domains (TMD),Abbreviations: BHK, baby hamster kidney; Sf21, Spodoptera frugiperda
21; ABC, ATP binding cassette; MRP1, multidrug resistance protein 1; P-gp,
P-glycoprotein; CFTR, cystic fibrosis trans-membrane conductance regulator;
BSA, bovine serum albumin; NBD, nucleotide binding domain; LTC4,
leukotriene C4; 8-N3ATP, 8-azidoadenosine 5′-triphosphate; PBS, phosphate-
buffered saline; EGTA, ethylene glycol-bis(β-aminoethyl ether)N,N,N,N-
tetraacetic acid; SDS, sodium dodecyl sulfate
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doi:10.1016/j.bbamem.2007.11.010similar to the topological structure of P-glycoprotein (P-gp)
[5–8], except that there is an extra N-terminal transmembrane
domain and a cytoplasmic linker region. This ATP-binding
cassette (ABC) transporter couples ATP binding and hydro-
lysis to solute, including anti-cancer drugs, transport across
biological membrane [9–12]. Due to this ATP-dependent anti-
cancer drug transport, the anti-cancer drug concentration
inside of the MRP1-over-expressing cancer cell is too low to
kill the cell.
Structural analyses of many prokaryotic ABC transporters,
including GlcV [13], MalK [14,15], HisP [16], MJ0796 [17]
and HlyB [18], revealed that the residues in Walker A motif, B
motif [19], ABC signature sequence, Q-loop, H-loop, D-loop
and an aromatic amino acid are involved in ATP binding and
hydrolysis. In order to study the relationship between the
structure and function of MRP1, we have mutated some of
these residues to similar or dissimilar amino acids, such as the
amino acids in Walker A motif K684 and K1333 [20,21] and
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and E1455 [20,23,24]; the aromatic amino acid W653 in
NBD1 and Y1302 in NBD2 [25]; and H827 and H1486 in H-
loop [26]. The results derived from these mutations provide a
deep insight of how the protein transports the anticancer drugs
out of the cell. However, substitution of the acidic amino acid
D792 in Walker B motif with a hydrophobic residue, such as
D792L- or D792A-mutated MRP1 [20,23], caused misfolding
of the protein and prevented further analysis of the mutated
protein. Although point mutations leading to misfolding or
mis-assembly of membrane proteins have been identified in
many hereditary diseases [27], little is known regarding the in
vivo folding mechanism of these multi-domain proteins [28].
Replacement of F508 residue in NBD1 of cystic fibrosis trans-
membrane-conductance regulator (CFTR) with other amino
acids suggested that hydrophobic side chain interactions of
F508 with surrounding residues are required for proper folding
of NBD2 and the domain–domain assembly of the protein
[29]. However, this mechanism of protein folding may not be
applied to the misfolding caused by substitution of the acidic
amino acid with a hydrophobic residue, such as D792L- or
D792A-mutated MRP1 [20,23]. Interestingly, structural analy-
sis of human wild-type MRP1-NBD1 in a complex with
Mg·ATP revealed that this acidic amino acid D792 in Walker B
motif forms a hydrogen-bond with the S685 in Walker A motif
[30]. In addition, the corresponding hydrogen-bond was also
identified in other ABC transporters, such as rat CFTR-NBD1
[31] and HlyB [18]. We suspected that D792A or D792L mu-
tation abolished the hydrogen-bond formation between D792
and S685 and resulted in misfolding of the mutated MRP1
protein. If that is the case, substitution of S685 with a residue
that prevents formation of this hydrogen-bond should also
result in misfolding of the protein. In this report we have
mutated S685 to T, A, C, H, D or N and found that only S685T
mutation formed complex-glycosylated mature protein, imply-
ing that the interaction between the hydroxyl group at 685 in
Walker A motif and the carboxyl group at 792 in Walker B
motif of NBD1 plays a crucial role for MRP1 protein folding.
In addition, all these mutants, except S685T, are temperature-
sensitive. However, even if they form mature protein at 27 °C,
these mature MRP1 proteins bearing S685A, S685C, S685D,
S685H or S685N mutations still do not have full ability to
transport LTC4, indicating that the hydroxyl group at 685 (in
serine or threonine) plays an important role for interacting with
Mg·ATP [30].
2. Materials and methods
2.1. Materials
Sodium orthovanadate, EGTA, Triton X-100, bovine serum albumin (BSA)
and ATP were purchased from Sigma. [14,15,19,20-3H]-leukotriene C4 (LTC4)
was from PerkinElmer Life Sciences. [α-32P]-8-N3ATP and [γ-
32P]-8-N3ATP
were from Affinity Labeling Technologies. PNGase F and endoglycosidae H
were derived from New England BioLabs. Fetal bovine serum was from Gemini
Bio-Products. QuikChange site-directed mutagenesis kit was from Stratagene.
Anti-mouse Ig conjugated with horseradish peroxidase was from Amersham
Biosciences. Chemiluminescent substrates for western blotting were from
Pierce.2.2. Site-directed mutagenesis of MRP1
Wild-type human MRP1 cDNA cloned into pNUT expression vector [32]
was used as a template for the in vitro mutagenesis. The serine residue at
position of 685 in Walker A motif was mutated to either threonine (T), alanine
(A), cysteine (C), histidine (H), asparagine (N) or aspartic acid (D) (Figs. 2A and
4A) by using the forward/reverse primers and the QuikChange site-directed
mutagenesis kit from Stratagene [20]. The forward and reverse primers used to
introduce these mutations are: S685T/forward, 5′-GTG GGC TGC GGA AAG
ACG TCC CTG CTC TCA GCC-3′; S685T/reverse, 5′-GGC TGA GAG CAG
GGA CGT CTT TCC GCA GCC CAC-3′; S685A/forward, 5′-GTG GGC TGC
GGA AAG GCG TCC CTG CTC TCA GCC-3′; S685A/reverse, 5′-GGC TGA
GAG CAG GGA CGC CTT TCC GCA GCC CAC-3′; S685C/forward, 5′-GTG
GGC TGC GGA AAG TGC TCC CTG CTC TCA GCC-3′; S685C/reverse, 5′-
GGC TGA GAG CAG GGA GCA CTT TCC GCA GCC CAC-3′; S685H/
forward, 5′-GTG GGC TGC GGA AAG CAC TCC CTG CTC TCA GCC-3′;
S685H/reverse, 5′-GGC TGA GAG CAG GGA GTG CTT TCC GCA GCC
CAC-3′; S685N/forward, 5′- GTG GGC TGC GGA AAG AAC TCC CTG
CTC TCA GCC-3′; S685N/reverse, 5′-GGC TGA GAG CAG GGA GTT CTT
TCCGCAGCC CAC-3′; S685D/forward, 5′-GTG GGC TGCGGAAAGGAT
TCC CTG CTC TCA GCC-3′; S685D/reverse, 5′-GGC TGA GAG CAG GGA
ATC CTT TCC GCA GCC CAC-3′. The mutation of D792S in Walker B motif
(Fig. 4A) was also introduced into the full length MRP1 cDNA by using the
same strategy shown above. The forward and reverse primers used to introduce
this mutation are: D792S/forward, 5′-GAC ATT TAC CTC TTC AGT GAT
CCC CTC TCA GC-3′ and D792S/reverse, 5′-GC TGA GAG GGG ATC ACT
GAA GAG GTA AAT GTC-3′. The underlined sequences are codons for
mutated residues. The serine residue at position of 685 in Walker A motif in
pDual/N-half/C-half [24] was mutated to either threonine (T) or alanine (A) by
using corresponding forward/reverse primers and the QuikChange site-directed
mutagenesis kit from Stratagene [20]. Recombinant viral DNA preparation and
viral particle production were carried out according to the procedures described
[24]. Regions containing these mutations were sequenced to confirm that the
correct clones were obtained.
2.3. Cell Culture and cell lines expressing MRP1
Baby hamster kidney (BHK-21) cells were cultured in DMEM/F12 medium
supplemented with 5% fetal bovine serum at 37 °C in 5% CO2. Subconfluent
cells were transfected with pNUT-MRP1/His in the presence of 20 mM HEPES
(pH 7.05), 137 mM NaCl, 5 mM KCl, 0.7 mM Na2HPO4, 6 mM dextrose and
125 mM CaCl2 [32]. Surviving individual colonies in media containing 200 μM
methotrexate were picked and amplified. Cells for membrane vesicle preparation
were grown in DMEM/F12 media containing 5% fetal bovine serum and
200 μM methotrexate in roller bottles (on a roller machine from BELLCO).
Spodoptera frugiperda 21 (Sf21) cells were cultured in Grace's insect cell
medium supplemented with 5% heat-inactivated fetal bovine serum at 27 °C.
Viral infection was performed according to the Invitrogen's recommendation.
2.4. Identification of MRP1 protein
Western blot was performed according to the method described previously
[20]. 42.4 monoclonal antibody was used to identify the NBD1-containing
fragments of MRP1, whereas 897.2 or 643.4 (recognize the fragment from 1248
to 1531) monoclonal antibody was used to detect the NBD2-containing
fragments [20,25]. The secondary antibody used was anti-mouse Ig conjugated
with horseradish peroxidase. Chemiluminescent film detection was performed
according to the manufacturer's recommendations (Pierce).
2.5. Membrane vesicle preparations
Membrane vesicles were prepared according to the procedure described
previously [20]. The membrane vesicle pellet was re-suspended in a solution
containing 10 mM Tris–HCl (pH 7.5), 250 mM sucrose and 1X protease
inhibitors (2 μg/ml aprotinine, 121 μg/ml benzamidine, 3.5 μg/ml E64, 1 μg/ml
leupeptin and 50 μg/ml Pefabloc). After passage through a Liposofast™ vesicle
extruder (Avestin, Ottawa, Canada) they were aliquoted and stored in −80 °C.
Table 1
Km (Mg·ATP) and Vmax (LTC4) Values of wild-type and mutant MRP1s
Vmax (pmol/mg/min)* Km (μM)*
MRP1 164.0±7.0 59.0±2.2
S685T 330.7±8.8 143.0±8.2
S685D 65.3±1.2 249.3±6.3
D792S 79.3±2.1 245.3±8.2
S685D/D792S 99.0±2.9 151.3±6.8
*Km (Mg·ATP) and Vmax (LTC4) values for wild-type, S685T, S685D, D792S
and S685D/D792S (n=3) were derived from the corresponding Michaelis–
Menten curves shown in Fig. 6. The P value for comparison of Km (Mg·ATP) of
wild-type versus S685T is 0.0001 and, therefore, the P values for other mutants
must be at most 0.0001.
Fig. 1. Model of Mg·ATP-bound form of wild-type nucleotide binding site 1 of
human MRP1. The nucleotide binding domain 1 (NBD1, 643–855) of human
MRP1 was modeled based on the crystal structure of Mg·ATP-bound form of
wild-type MRP1-NBD1 [30], whereas the NBD2 was modeled using the
MJ0796-E171Q homodimer [17] as a template. The green ribbon indicates the
residues from NBD1, whereas the gray ribbon represents the residues from
NBD2. The gray sticks on the green ribbon represent S685 in Walker A motif
and D792 inWalker B motif. ATP is shown in stick representation. Red indicates
oxygen atom; blue, nitrogen; yellow, phosphorus; cyan, Mg++ ion.
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ATP-dependent LTC4 transport was assayed by a rapid filtration technique
[33,34]. The assays were carried out in a 30-μl solution containing 3 μg of
membrane proteins, 50 mM Tris–HCl (pH 7.5), 250 mM sucrose, 10 mM
MgCl2, 200 nM LTC4 (17.54 nCi of
3H-labeled LTC4) and 4 mMAMP (used as
negative control) or 4 mM ATP (or as indicated in the figure legend). After
incubation at 37 °C for indicated time, the samples were brought back to ice and
diluted with 1 ml of ice-cold 1 X transport buffer (50 mM Tris–HCl, pH 7.5,
250 mM sucrose and 10 mM MgCl2) and trapped on nitrocellulose membranes
(0.2 μm) that had been equilibrated with 1X transport buffer. The filter was
then washed with 10 ml of ice-cold 1 X transport buffer, air-dried and placed in
a 10-ml biodegradable counting scintillant (Amersham Pharmacia Biotech). The
radioactivity bound to the nitrocellulose membrane was determined by liquid
scintillation counting (Beckman LS 6000SC).
2.7. Endoglycosidase H or PNGase F treatment of proteins
The core-glycosylated oligosaccharides were removed by digestion with
endoglycosidase H. Cells were lysed with 2% SDS and sonicated for 20 pulses
to break the genomic DNA. 10 μg of the cell lysates were digested overnight at
37 °C with 200 units (New England BioLabs) of endoglycosidase H in a 200-μl
solution containing 50 mM sodium acetate buffer (pH 5.3), 0.5% NP-40, 1%
β-mercaptoethanol, 0.2% SDS (final concentration), 10 μg BSA and 1X
protease inhibitors [23].
The core-glycosylated and the complex-glycosylated oligosaccharides were
removed by digestion with PNGase F. 10 μg of the cell lysates were digested
overnight at 37 °C with 100 units (New England BioLabs) of PNGase F in a
200-μl solution containing 50 mM sodium phosphate buffer (pH 7.5), 0.5%
NP-40, 1% β-mercaptoethanol, 0.2% SDS (final concentration), 10 μg BSA and
1 X protease inhibitors [35].
Following digestion, 800 μl of cold ethanol was added to precipitate the
proteins. The pellets were collected by centrifugation at 4 °C for 15 min. The
proteins were resolved by SDS-PAGE (7%), electroblotted to nitrocellulose
membrane and probed with monoclonal antibodies against human MRP1
protein [20].
2.8. Photoaffinity labeling of MRP1 protein
Vanadate preparation and photoaffinity labeling of MRP1 protein were
performed according to procedures described previously [20]. Briefly, photolabel-
ing experiments were carried out in a 10-μl solution containing 10 μg ofmembrane
proteins, 40 mM Tris–HCl (pH 7.5), 2 mM ouabain, 10 mM MgCl2, 0.1 mM
EGTA, 800 μM vanadate and either 10 μM [α-32P]-8-N3ATP or 10 μM [γ-
32P]-8-
N3ATP. After incubation at 37 °C for 2 min, the samples were brought back to ice
and UV-irradiated for 2 min. The labeled proteins were separated by polyacryl-
amide gel (7%) electrophoresis and electro-blotted to a nitrocellulose membrane.
2.9. Statistical analysis
The results in Table 1 were presented as means±SD from three independent
triplicate-experiments. The two-tailed P value was calculated based on theunpaired t test from GraphPad Software Quick Calcs. By conventional criteria,
if P value is less than 0.05, the difference between two samples is considered to
be statistically significant.3. Results
3.1. Substitution of S685 in Walker A motif with an amino acid
without the hydroxyl group affects the protein folding and
processing
Structural analysis of wild-type MRP1-NBD1 revealed that
the S685 residue in Walker A motif forms a tight hydrogen-
bond with the D792 in Walker B motif [30]. Substitution of the
D792 with either leucine or alanine caused misfolding of the
mutated MRP1 protein [20,23]. We suspected that D792A or
D792L mutation abolished the hydrogen-bond formation
between D792 and S685 and resulted in misfolding of the
mutated MRP1 protein. In this report we tested whether
substitution of S685 with A, C, H, N or T (Fig. 2A) would
also have an effect on the protein folding or not. In order to
determine whether or not some of the substitutions, such as T or
C, would form hydrogen-bond with D792, the model of
NBD1·ATP·ATP·NBD2 sandwich structure was established
(Fig. 1). This model indicates that some of the substitutions,
such as T, H or C, could potentially form hydrogen-bond with
the carboxyl group in D792, whereas the other mutation, such as
A, would not.
Substitution of the S685 with an amino acid that prevents
formation of the hydrogen-bond with D792, such as S685A,
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2B). In addition, majority of S685A is core-glycosylated
immature protein at 37 °C, with an apparent molecular weight
of ∼165 kDa (Fig. 2B). Of note, a degradation product
(∼37 kDa) was detected by monoclonal antibody 42.4 [20]
against NBD1 in S685A, but not in wild-type MRP1, implying
that this mutant MRP1 protein synthesized in BHK cell is not as
stable as wild-type. In order to test whether the hydroxyl group
in S685 plays such an important role for the protein folding, this
serine residue was mutated to threonine (S685T in Fig. 2A).
Interestingly, S685T mutant produced similar amount of
complex-glycosylated mature protein as wild-type (Fig. 2B),
implying that the hydroxyl group in threonine plays a similar
role as the one in serine residue. We, then, mutated this serine
residue to other amino acids, such as S685C, S685N and S685H
(Fig. 2A), that could potentially form hydrogen-bond with theFig. 2. Substitution of S685 in Walker A motif of NBD1 with an amino acid
residue that prevents formation of hydrogen-bond with the D792 in Walker B
motif significantly affects the protein folding. (A) Sequence alignment of the
Walker A and B motifs in NBD1 of MRP1. The highlighted letters indicate that
the serine residue at 685 was substituted with the amino acid residues indicated
at that position. The definition of S685A means that the S685 in Walker A motif
was substituted with an alanine residue while the Walker B motif was un-
mutated. (B) Expression of wild-type and variant mutants of human MRP1
proteins in BHK cells at 37 °C. Cells were lysed with 2% SDS and loaded to a
7% polyacrylamide gel. The amounts of proteins loaded in the gel are indicated
at the bottom of the gel. Molecular weight markers (kDa) are indicated on the
left. MRP1 and imMRP1 on the right indicate the complex-glycosylated mature
MRP1 and the core-glycosylated immature MRP1 proteins that were detected in
western blot by employing the monoclonal antibody 42.4 against NBD1 [20].D792 residue in Walker B motif. Although the ratio of mature
versus immature MRP1 protein at 37 °C in S685C or S685N is
slightly higher than in S685A (Figs. 2B and 3A), substitution of
the S685 with either cysteine or asparagine cannot completely
rescue the misfolding (Fig. 2B). S685H is an interesting mutant
that produces similar amount of immature MRP1 protein and 37
kDa degradation product as S685A, but the amount of complex-
glycosylated mature S685H is significantly higher than that of
S685A, S685C or S685N (Fig. 2B), implying that the histidine
residue at that position might form a weak hydrogen bond or salt
bridge with the D792 in Walker B motif.
3.2. S685A, S685C, S685H and S685N are temperature
sensitive mutants
Serine residue at 685 may also interact with the metal
cofactor [30] and the β-phosphate of the bound ATP [17] and,
thus, participates Mg·ATP binding. However, the amounts of
mature MRP1 proteins produced by these mutants at 37 °C (Fig.
2B) may not be appropriate for functional analysis. We then
tested whether these mutants are temperature sensitive variants
or not. As shown in Fig. 3A, all these mutants, including
S685H, S685N, S685C and S685A, mainly form complex-
glycosylated mature MRP1 proteins at 27 °C. In addition, the
amount of MRP1 protein accumulated in BHK cells at 27 °C
increased at least four fold (comparing to the amount of MRP1
protein accumulated in BHK cells at 37 °C). However, the
amounts of MRP1 mutant proteins accumulated in BHK cells at
27 °C is still much less than that of wild-type or S685T (Fig.
3A), probably due to the mutants are not as stable as wild-type,
even at 27 °C. This hypothesis is confirmed by the fact that the
two degradation products, ∼75 kDa and ∼35 kDa, were clearly
detected by mAb against NBD2 in the mutants of S685H,
S685N, S685C or S685A grown at 27 °C, but not in wild-type
or S685T (Fig. 3A).
If these mutants, including S685H, S685N, S685C and
S685A, form complex-glycosylated mature MRP1 proteins at
27 °C, they should be distinguished from the core-glycosylated
immature protein by digestion with endoglycosidase H [36].
The results in Fig. 3B clearly indicate that the 165 kDa
immature MRP1s, including S685H, S685N, S685C and
S685A, are sensitive to endoglycosidase H digestion whereas
the 190-kDa mature MRP1 proteins, regardless whether they
are wild-type or mutants, are not (Fig. 3B). In contrast, both 165
and 190 kDa proteins are sensitive to the PNGase F digestion
(Fig. 3C).
3.3. Switching the two residues in Walker A and B motifs did
not rescue the misfolding
Our results indicate that the interaction between the hydroxyl
group of the residue at 685, regardless whether it is a serine or
threonine, and the carboxyl group of D792 plays a crucial role
for MRP1 protein folding and processing. We, then, tested
whether switching these two residues, i.e., substituting the
Walker A S685 with aspartic acid and replacing the Walker B
D792 with serine (Fig. 4A, S685D/D792S), would promote the
Fig. 3. S685A, S685C, S685H and S685N are temperature-sensitive mutants. (A)Wild-type and mutant MRP1 expression at either 27 °C or 37 °C. Cells were grown at
either 27 °C or 37 °C as indicated on top of the gel, lysed with 2% SDS and loaded to a 7% polyacrylamide gel. (B) The complex-glycosylated mature MRP1 protein is
endoglycosidase H resistant. The samples were incubated in the absence (−) or in the presence (+) of endoglycosidase H according to the procedure described under
Materials and methods. (C) Both core- and complex-glycosylated MRP1 proteins are sensitive to PNGase F. The samples were incubated in the absence (−) or in the
presence (+) of PNGase F according to the procedure described under Materials and methods. Molecular weight markers (kDa) are indicated on the left. MRP1, im
MRP1 and deMRP1 on the right indicate the complex-glycosylated mature MRP1, the core-glycosylated immature MRP1 and the de-glycosylatedMRP1 proteins that
were detected in western blots by employing the monoclonal antibodies (mAb 643.4 against NBD2 was used in panel A, whereas mAb 42.4 against NBD1 and mAb
897.2 against NBD2 were used in panels B and C) against MRP1.
458 R. Yang et al. / Biochimica et Biophysica Acta 1778 (2008) 454–465proper folding. The results in Fig. 4B indicated that substitution
of the Walker A serine residue with aspartic acid (S685D) or
Walker B mutant D792S resulted in misfolding of the protein. In
addition, switching these two residues, S685D/D792S, also did
not rescue the misfolding (Fig. 4B). All these three mutants,
including S685D, D792S and S685D/D792S, are temperature-
sensitive variants (Fig. 4C) that are not as stable as wild-type(Fig. 4C) and mainly degraded by proteasome (data not shown).
The core-glycosylated S685D, D792S and S685D/D792S
mutants are sensitive to endoglycosidase H digestion whereas
the 190-kDa mature MRP1 proteins are not (Fig. 4D). In con-
trast, both 165 kDa core-glycosylated and 190 kDa complex-
glycosylated MRP1 proteins are sensitive to the PNGase F
digestion (Fig. 4E).
Fig. 4. Switching the two residues in Walker A serine 685 andWalker B aspartic acid 792 did not rescue the misfolding. (A) Sequence alignment of theWalker A and B
motifs in NBD1 of MRP1. The highlighted letters indicate that the S685 in Walker A motif was substituted with the D residue (S685D) whereas the D792 in Walker B
motif was substituted with the S residue (D792S). (B) Expression of wild-type and variant mutants of human MRP1 proteins in BHK cells at 37 °C. The experiments
were carried out as described in Fig. 2B. (C) S685D, D792S and S685D/D792S are temperature-sensitive mutants. The experiments were carried out as described in
Fig. 3A. (D) The complex-glycosylated mature MRP1 protein is endoglycosidase H resistant. The experiments were carried out as described in Fig. 3B. (E) Both core-
and complex-glycosylated MRP1 proteins are sensitive to PNGase F. The experiments were carried out as described in Fig. 3C.
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with a residue that eliminates the hydroxyl group or carboxyl
group significantly affects the ATP-dependent LTC4 transport
Since S685 in Walker A motif or D792 in Walker B motif is
not only involved in hydrogen-bond formation between them,
but also in interacting with the β-phosphate of the bound ATP
and the metal co-factor [17,30], thus, these mutations may not
only affect the protein folding, but also the ATP-dependent
solute transport. In order to test whether these mutations affect
the ATP-dependent solute transport, membrane vesicles wereprepared from the cells grown at 27 °C. Although the amounts
of MRP1 mutants in the membrane vesicles are much less than
that of wild-type or S685T (Fig. 5A), majorities of these mutants
in membrane vesicles prepared from the cells grown at 27 °C are
complex-glycosylated mature MRP1s (Fig. 5A). In order to
compare their relative transport activities, the transport assays
were carried out in a total of 3 μg of membrane proteins
containing similar amount of MRP1 protein by adding varying
amount of membrane vesicles prepared from parental BHK cells
(Fig. 5B legend). For un-known reasons, the ATP-dependent
LTC4 transport activity catalyzed by S685T is significantly
Fig. 5. ATP-dependent LTC4 uptake by membrane vesicles prepared from wild-type and mutant MRP1s. (A) Relative amounts of MRP1 proteins in membrane
vesicles containing wild-type or mutant MRP1s. The membrane vesicles containing mutant MRP1s were prepared from cells grown at 27 °C so that majorities of the
mutant MRP1s are complex-glycosylated mature proteins. The amounts of membrane vesicle proteins loaded in the gel are indicated on the top. MRP1 on the left
indicates the 190-kDa complex-glycosylated mature MRP1 proteins that were detected in western blot by employing the monoclonal antibody 42.4 [20]. The
intensities of the 190-kDa bands were determined by a scanning densitometer. The mean ratios (n=3), considering the amount of wild type MRP1 as 1, of the mutant
proteins are listed at the bottom of the gel. (B) Relative rate of ATP-dependent LTC4 transport activity. The assays were carried out in a 30-μl solution containing 3 μg
of membrane vesicles (the amount of MRP1 protein determined in panel Awas adjusted to a similar amount by adding varying amount of membrane vesicles prepared
from parental BHK cells) and 4 mMAMP (used as a control) or 4 mMATP at 37 °C for 4 min. The amount of LTC4 bound to the membrane vesicles in the presence of
4 mM AMP was subtracted from the corresponding samples in the presence of 4 mM ATP. The data are means±S.D. of four triplicate-determinations.
Fig. 6. Mg·ATP-dependent LTC4 transport by membrane vesicles containing
wild-type and mutant MRP1 proteins. Membrane vesicles prepared in Fig. 5
were used to do the transport experiments. The transport experiments were
performed according to the methods described in Materials and methods.
Briefly, the assays were carried out in a 30-μl solution containing 3 μg of
membrane vesicles, 10 mM MgCl2 and varying concentrations of AMP (as a
control) or ATP at 37 °C for 1 min. Since the amounts of MRP1 proteins
determined in Fig. 5A were different, the amounts of membrane vesicles used
in these experiments were adjusted to a similar amount of MRP1 by adding
varying amounts of membrane vesicles prepared from parental BHK cells:
0.81 μg of wild-type MRP1+2.19 μg BHK; 0.82 μg of S685T+2.18 μg
BHK; 3.00 μg of S685D; 2.31 μg of S685D/D792S+0.69 μg BHK; 1.88 μg
of D792S+1.12 μg BHK. The data are the means±S.D. of triplicate
determinations.
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of the serine residue with an alanine (S685A) that prevents the
interactions with the magnesium co-factor and the β-phosphate
of the bound ATP significantly reduced the ATP-dependent
LTC4 transport activity (Fig. 5B). However, S685A mutation
exerts much higher transport activity than that of the membrane
vesicles containing CFTR (Fig. 5B), implying that this mutation
did not completely abolish the ATP-dependent LTC4 transport
activity. Interestingly, substitution of the Walker A serine
residue with a cysteine (S685C), a histidine (S685H), an aspartic
acid (S685D) or an asparagine (S685N) that may potentially
interact with metal co-factor and the β-phosphate of the bound
ATP exerts approximately two fold higher transport activity
than that of S685A (Fig. 5B).
Substitution of the Walker B aspartic acid with a serine
residue (D792S) that potentially interacts with the magnesium
co-factor also exerts approximately two fold higher transport
activity than that of S685A (Fig. 5B). In addition, switching
these two residues, i.e., S685D/D792S, exerts even higher
transport activity than that of S685D or D792S (Fig. 5B),
implying that the interactions of these residues with metal co-
factor and the β-phosphate of the bound ATP participate the
ATP-dependent LTC4 transport.
3.5. The Km (Mg·ATP) values of S685D, D792S and
S685D/D792S are significantly higher than that of wild-type
MRP1
Six oxygen atoms, including the γ-oxygen of S685 residue
in the Walker A motif and the δ-oxygen of D792 in the Walker
461R. Yang et al. / Biochimica et Biophysica Acta 1778 (2008) 454–465B motif, interact with the magnesium co-factor to form the
octahedral coordination geometry [30]. In addition, the γ-
oxygen of S685 residue in the Walker A motif interacts with the
β-phosphate of the bound ATP [17]. Therefore, it is reasonable
to speculate that substitutions of S685 and D792 with residues
that potentially interfere the interactions might decrease the
binding force for Mg·ATP and affect ATP-dependent solute
transport activity. To test this hypothesis, varying concentra-
tions of ATP were utilized to do the ATP-dependent LTC4
transport in the presence of 10 mMMgCl2 (Fig. 6). As shown in
Fig. 6 and Table 1, the Vmax (LTC4) value of S685T is
significantly higher than that of wild-type, consistent with the
results derived from a solution containing 4 mM ATP and
10 mMMgCl2 (Fig. 5B). Although the exact mechanism of why
S685T is more active than the wild-type is not clear, the higher
Km (Mg·ATP) value of S685T (Table 1) might be a factor.
However, the Km (Mg·ATP) values of S685D, D792S andFig. 7. Photolabeling of wild-type and mutant MRP1 proteins with either [α-32P]-8-N
binding. Membrane vesicles prepared in Fig. 5 were used to do the photolabeling
containing 10 μg membrane vesicle proteins (the amount of MRP1 protein determi
membrane vesicles prepared from parental BHK cells), 10 μM [α-32P]-8-N3ATP (α)
reaction mixture was subjected to UV-irradiation (+) or without UV-irradiation (−) on
membrane. Molecular weight markers (kDa) are indicated on the left. MRP1 on the
mutated MRP1 mainly affects ATP binding at the mutated NBD1, but not the ATP hyd
the pDual/N-half/C-half and expressed in Sf21 insect cells [24]. The membrane
photolabeling as described in panel A. NH and CH on the right indicate the 32P-labe
were repeated three times and the counts in each band were determined by Instant IS685D/D792S are even higher than that of S685T (Table 1),
whereas the Vmax (LTC4) values of these mutants are much
lower than that of wild-type. We simply interpreted these results
as that the mutations of S685D, D792S and S685D/D792S not
only affected ATP binding but also ATP hydrolysis and ATP-
dependent solute transport. These results imply that the Km
(Mg·ATP) value of S685A should even be higher than that of
S685D or D792S. Unfortunately, the Km (Mg·ATP) value of
S685A cannot be accurately determined due to the low transport
activity.
3.6. Walker A serine and Walker B aspartic acid mutations
affect ATP binding
The above results [higher Km (Mg·ATP) values] imply that
the Walker A serine and Walker B aspartic acid mutations affect
Mg·ATP binding. To test this hypothesis, similar amounts of3ATP or [γ-
32P]-8-N3ATP. (A) Walker A and B mutants mainly affect nucleotide
experiments. Photolabeling experiments were carried out in a 10-μl solution
ned in Fig. 5A was adjusted to a similar amount by adding varying amount of
or 10 μM [γ-32P]-8-N3ATP (γ) and 800 μM vanadate at 37 °C for 2 min. The
ice for 2 min, separated by SDS-PAGE (7%) and electroblotted to a nitrocellulose
right of the gel indicates the 32P-nucleotide labeled MRP1 proteins. (B) S685A-
rolysis at the un-mutated NBD2. S685A or S685T mutation was introduced into
vesicles prepared from the viral particle infected Sf21 cells were used to do
led NBD1-containing N-half and NBD2-containing C-half. All the experiments
mager [20].
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D792S-mutated MRP1s were used to do photo-affinity labeling
at 37 °C with either [α-32P]-8-N3ATP or [γ-
32P]-8-N3ATP in
the presence of vanadate. As shown in Fig. 7A, MRP1 protein,
regardless whether it is wild-type or mutant, is labeled by
[γ-32P]-8-N3ATP without UV-irradiation. These results are in
harmony with our previous observation that MRP1 protein
might be auto-phosphorylated [20]. However, the amount of
labeling on wild-type MRP1 with [γ-32P]-8-N3ATP, including
the phosphorylation and UV-cross-linking events, is much less
than that of the labeling with [α-32P]-8-N3ATP (Fig. 7A),
indicating that most of the bound ATP is hydrolyzed. For
S685A-mutated MRP1, the amounts of labeling with either
[α-32P]-8-N3ATP or [γ-
32P]-8-N3ATP are much less than the
corresponding labeling on wild-type MRP1 (Fig. 7A), implying
that S685A mutation significantly affects the Mg·ATP binding.
However, the amount of labeling on S685A with [α-32P]-8-
N3ATP is higher than that of labeling with [γ-
32P]-8-N3ATP
(Fig. 7A), implying that certain amount of the bound ATP is
hydrolyzed. Similar results (as S685A) were obtained from
S685D-, D792S- and S685D/D792S-mutated MRP1s (Fig. 7A),
implying that all these mutations affect Mg·ATP binding. In
contrast, the labeling of S685T with [γ-32P]-8-N3ATP is
significantly higher than the corresponding labeling on wild-
type MRP1 (Fig. 7A). In addition, the labeling of S685T with
[α-32P]-8-N3ATP is also higher than the corresponding labeling
on wild-type MRP1 (Fig. 7A). The ratio of [γ-32P]-8-N3ATP
labeling, after subtracting the labeling without UV-irradiation,
versus [α-32P]-8-N3ATP labeling on wild-type MRP1 is
approximately 0.3, whereas this ratio for S685T is approxi-
mately 0.6, implying that ATP bound to the S685T-mutated
MRP1 may not be efficiently hydrolyzed. However, the ATP-
dependent LTC4 transport activity of S685T-mutated MRP1 is
much higher than that of wild-type (Figs. 5 and 6). In order
to solve this puzzle, S685T was introduced into pDual/N-half/
C-half expression vector [24,25] and expressed in Sf21 cells.
Membrane vesicles prepared from Sf21 cells were used to do
the photo-affinity labeling at 37 °C with either [α-32P]-8-
N3ATP or [γ-
32P]-8-N3ATP. The [γ-
32P]-8-N3ATP labeling of
wild-type NBD1-containing N-half fragment is much higher
than the corresponding labeling in NBD2-containing C-half
fragment (Fig. 7B), whereas the [α-32P]-8-N3ATP labeling of
wild-type NBD2-containing C-half fragment is much higher
than the corresponding labeling in wild-type NBD1-containing
N-half fragment (Fig. 7B), implying that ATP bound to the
wild-type NBD2 is efficiently hydrolyzed. The [γ-32P]-8-
N3ATP labeling of S685A-mutated-NBD1-containing N-half
fragment is significantly lower than the corresponding labeling
in wild-type NBD1-containing N-half (Fig. 7B), implying that
S685A mutation affects Mg·ATP binding at the mutated NBD1.
However, the [α-32P]-8-N3ATP labeling of the un-mutated
NBD2-containing C-half of S685A-mutated MRP1 is much
higher than the [γ-32P]-8-N3ATP labeling of the same fragment
(Fig. 7B), indicating that ATP bound to this NBD2 is
hydrolyzed. In contrast, the [γ-32P]-8-N3ATP or [α-
32P]-8-
N3ATP labeling of S685T-mutated-NBD1-containing N-half is
significantly higher than the corresponding labeling on the wild-type N-half (Fig. 7B), presumably the S685T mutation
increased affinity for 8-N3ATP at the mutated NBD1. In
addition, the [γ-32P]-8-N3ATP labeling of S685T-mutated-
NBD1-containing N-half is much higher than that of the
labeling on the un-mutated NBD2-containing C-half (Fig. 7B)
and the [α-32P]-8-N3ATP labeling of the un-mutated NBD2-
containing C-half of S685T-mutated MRP1 is much higher
than the [γ-32P]-8-N3ATP labeling of the same fragment
(Fig. 7B), indicating that ATP bound to this NBD2 is efficiently
hydrolyzed.
4. Discussion
Structural analyses of human MRP1-NBD1 [30], mouse
CFTR-NBD1 [31] and HlyB-NBD [18] revealed that Walker A
serine residue forms a strong hydrogen-bond with the Walker B
aspartic acid. We have found that substitution of the Walker B
D572 of human CFTR-NBD1 with an asparagine [37] or
substitution of the Walker B D792 of human MRP1-NBD1 with
an alanine or a leucine residue [23] resulted in misfolding of the
protein, implying that hydrogen-bond formation between the
Walker A serine residue and the Walker B aspartic acid may
play a crucial role for the protein folding. In this report we tested
this hypothesis by substituting the S685 with a residue that
might potentially prevent the hydrogen-bond formation
between these two residues. Indeed, substitution of S685 with
an alanine residue that eliminates the hydroxyl group in this
serine residue resulted in misfolding of the protein at 37 °C
(Figs. 2B and 3), indicating that the hydrogen-bond formation
between these two residues may play a crucial role for the
protein folding. If that is the case, replacement of the hydroxyl
group in this serine residue with a thiol group, i.e., S685C
mutation [Computer simulation (Fig. 1) of S685C-mutated
NBD1 indicates that the distance between the thiol group of
C685 and the carboxyl group of D792 is ∼2.85 Å], should
result in a complex-glycosylated mature MRP1 protein. In fact,
although the ratio of mature S685C versus immature protein at
37 °C is slightly higher than that of S685A (Fig. 3A), majority
of S685C are high-mannose core-glycosylated (endoglycosi-
dase H-sensitive) immature protein at 37 °C (Figs. 2B, 3A
and B), indicating that the hydrogen-bond formation between
these two residues is not the only factor that affects the protein
folding. The results derived from S685H, S685N and D792S
also support the above conclusion. For example, although
majority of the S685H [The five-member imidazole ring in
histidine might be partial positively charged under physiolo-
gical pH and computer simulation (Fig. 1) of S685H-mutated
NBD1 indicates that the distance between the nitrogen atom of
H685 and the carboxyl group of D792 is ∼1.93 Å] are core-
glycosylated immature protein at 37 °C (Figs. 2B and 3A), the
ratio of mature S685H versus immature protein at 37 °C is
much higher than that of S685A (Figs. 2B and 3A), implying
that the hydrogen-bond formation between these two residues
does play a role for the protein folding. Substitution of the
hydroxyl group in S685 with a carboxyl group (S685D) will
introduce a negatively charged group at that position and may
repel each other with the negatively charged D792. As S685A
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D685 (the S685D mutation) and D792 resulted in misfolding
of the protein (Fig. 4B and C). Interestingly, switching these
two residues, i.e., S685D/D792S, might resume the hydrogen-
bond formation between them but did not rescue the
misfolding of the protein (Fig. 4B and C). Therefore, the
mechanism by which these substitutions affect the protein
folding is not yet clear. Presumably, substitutions of the Walker
A serine with an aspartic acid and/or the Walker B aspartic acid
with a serine residue might alter the interactions of the
hydroxyl group in S685 or the carboxyl group in D792 with
surrounding residues and cause overall conformational changes
of the full-length molecule that affects the protein folding and
trafficking to the plasma membrane. This hypothesis is
supported by the fact that even though these mutants form
complex-glycosylated mature protein at 27 °C, they are still not
as stable as wild-type (Figs. 3A and 4C), implying the
conformations of these mutants are different from that of wild-
type. Computer simulation of full-length MRP1 molecule using
other ABC transporter structure, such as Sav1866 [38], as a
template may help to find the conformational changes induced
by these mutations. However, computer simulation model may
not reflect the real structure of this big membrane-bound
glycoprotein. In contrast to other mutations, substitution of the
Walker A serine residue with a threonine (S685T) that does not
change the position of the hydroxyl group, except introducing
an extra methyl group, results in complex-glycosylated mature
MRP1 protein (Figs. 2B and 3). Therefore, the precise
interactions of the hydroxyl group at 685 or carboxyl group
at D792 with the surrounding residues including D792 and/or
S685 play a crucial role for the protein folding.
If the above conclusion is a common feature of ABC
transporters, substitution of the corresponding residues in other
NBDs with amino acid that potentially abolishes the interactions
with surrounding residues should also result in misfolding of the
protein. Clearly, substitution of D555 in NBD1 or D1200 in
NBD2 of P-gp with an asparagine did not cause misfolding of
the protein [39]. In addition, substitutions of the Walker B motif
D1454 and E1455 in NBD2 of MRP1 with a leucine residue
(D1454L/E1455L) also did not cause misfolding of the protein
[20]. In order to rule out the possibility that the double mutant
D1454L/E1455L might rescue the misfolding caused by D14
54L mutation, we have made single mutants including D1454L,
D1454N, S1334A, S1334T, S1334C, S1334H, S1334D and
S1334N. It turned out that none of these mutations caused mis-
folding of the protein (manuscript in preparation), implying that
the stereo-structure of NBD2 may be different from that of
NBD1 and interactions of the hydroxyl group inWalker A serine
residue of NBD2 and/or the carboxyl group inWalker B aspartic
acid of NBD2 with surrounding residues are not very important
for the protein folding.
Structural analyses of human MRP1-NBD1 revealed that the
tight hydrogen-bond formation between S685 and D792
stabilizes the protein in a proper conformation and completes
the nucleotide binding site [30]. The γ-oxygen of the Walker A
serine residue may also interact with the β-phosphate of the
bound ATP [17]. In addition, the γ-oxygen of the Walker Aserine residue and the δ-oxygen of the Walker B aspartate
residue interact, along with other four oxygen atoms from β- and
γ-phosphate of the bound ATP and water molecules, with Mg++
ion to form the octahedral coordination geometry [13,14,17,
30,31,40]. Thus, even though the corresponding mutations form
complex-glycosylated mature protein [39], the mutations, such
as D555N and D1200N in P-gp, eliminating the carboxyl group
in Walker B motif significantly reduced the magnesium-
dependent ATP binding [39,41,42]. Corresponding mutations
in CFTR affect ATP-dependent chloride channel gating [43–45].
It is also true for the corresponding mutations in Walker B motif
of NBD2 in MRP1, such as D1454L (manuscript in preparation)
and D1454N [46], have a significant effect on the ATP-
dependent LTC4 transport. Functional analyses of the Walker A
serine mutants in NBD1, including membrane vesicles contain-
ing the complex-glycosylated mature and endoglycosidase H-
resistant (Figs. 3B and 4D) S685H, S685C, S685A, S685D,
S685N, D792S and S685D/D792S prepared from these tempe-
rature sensitive variants (Figs. 3 and 4) grown at 27 °C, indicate
that these mutations affect ATP binding and ATP-dependent
LTC4 transport (Table 1 and Figs. 5–7). Interestingly, although
the double mutant S685D/D792S did not rescue the misfolding
of the protein, the ATP-dependent LTC4 transport activity of this
double mutant was significantly higher than the single mutant
S685D or D792S (Fig. 5 and Table 1), implying that the
hydrogen-bond formation between D685 and S792 may play a
role in stabilizing the protein in a proper conformation [30]. In
addition, substitution of the Walker A serine residue with a
threonine (S685T) without changing the position of the
hydroxyl group exerted higher affinity for 8-azido-ATP (Fig. 7)
at the mutated NBD1 and significantly increased ATP-depen-
dent LTC4 transport activity (Table 1 and Figs. 5 and 6),
emphasizing the importance of the hydroxyl group located at
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